Clinical Study | Office of Clinical Research

Recurrent Respiratory Papillomatosis (Rrp) Treatment With A Dna Vaccine

Posted Date: Dec 22, 2020

Investigator: Aaron Friedman
Specialties:
Type of Study: Device & Drug

Patients with HPV-6 and /or HPV-11 based RRP will be treated with a series of intramuscular injections of a DNA Vaccine and followed for a period of two years to see if their RRP inter-surgical interval increases.

Criteria:

Adult Patients With Pre-Existing Hpv-6 And/Or Hpv-11 Based Rrp Requiring 2 Surgical Procedures Per Year For The 3 Years Prior To Study Entry.

Keywords:

Rrp, Papilloma, Immunotherapy

For More Information:

Aaron Friedman
513-475-8400
friedma5@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List